|Videos|April 14, 2017

How Can Antibiotic Allergies Affect Stewardship

Emily Heil, PharmD, BCPS-AQ ID, assistant professor at the University of Maryland School of Pharmacy, and Contagion® Editorial Advisory Board Member, discusses how antibiotic allergies can affect stewardship.

Emily Heil, PharmD, BCPS-AQ ID, assistant professor at the University of Maryland School of Pharmacy, and Contagion® Editorial Advisory Board Member, discusses how antibiotic allergies can affect stewardship.

Interview Transcript (slightly modified for readability

“Allergies as [they] relate to stewardship is another really important area for stewardship programs to intervene on. Antibiotic allergies are not benign, and having an antibiotic allergy label on a patient chart can really change how a patient is treated.

There’s data that patients that report penicillin allergies receive less-ideal antibiotic therapy, and have less-than-optimal outcomes, compared to their counterparts that do not report a penicillin allergy.

Good documentation of allergy histories, considering things like penicillin skin testing to rule out allergies or graded challenges of antibiotics are ways that stewardship teams can optimize antimicrobial therapy in patients that do report allergies.

So, allergies should definitely be considered as a potential intervention for stewardship programs.”


Related to this article

Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.
Household Contacts Drive Most Hepatitis B Exposures in Young Children
Karen B. Jacobson, MD, MPH, of Kaiser Permanente Northern California, presented data at IDWeek 2026 showing 58.2% of children younger than five years exposed to active hepatitis B in the home were exposed by someone other than their birth mother, a risk maternal screening alone would miss under the CDC’s revised birth dose recommendation.